These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. Smith CM; Watson DI; Michael MZ; Hussey DJ World J Gastroenterol; 2010 Feb; 16(5):531-7. PubMed ID: 20128019 [TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux disease: From heartburn to cancer. Patti MG; Waxman I World J Gastroenterol; 2010 Aug; 16(30):3743-4. PubMed ID: 20698034 [TBL] [Abstract][Full Text] [Related]
8. ROLE OF MICRORNA IN PREDICTING OF ADENOCARCINOMA DEVELOPMENT IN BARRETT’S ESOPHAGUS. Tsitskarava AZ; Zaraiskiy MI; Vasilevskiy DI; Lapshin AS; Popova VF; Smirnov AA; Lyubchenko ME Vestn Khir Im I I Grek; 2016; 175(4):13-4. PubMed ID: 30457256 [TBL] [Abstract][Full Text] [Related]
10. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Whitson MJ; Falk GW Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196 [TBL] [Abstract][Full Text] [Related]
11. Management of Barrett's esophagus free of dysplasia. DeMeester SR Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346 [TBL] [Abstract][Full Text] [Related]
12. Should patients with GERD be screened once at least for Barrett's epithelium? Con: Patients with GERD should be screened once at least for Barrett's esophagus--medicine or magic? Moayyedi P Am J Gastroenterol; 2004 Dec; 99(12):2293-5. PubMed ID: 15571570 [No Abstract] [Full Text] [Related]
13. Risk factors for neoplastic progression in Barrett's esophagus. Wiseman EF; Ang YS World J Gastroenterol; 2011 Aug; 17(32):3672-83. PubMed ID: 21990948 [TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus and risk of esophageal adenocarcinoma. Cossentino MJ; Wong RK Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412 [TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma. Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870 [TBL] [Abstract][Full Text] [Related]
17. [Barrett's esophagus: a report of 4 cases]. Li FH Zhonghua Fang She Xue Za Zhi; 1989 Oct; 23(5):269-70. PubMed ID: 2627810 [TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms of Barrett's esophagus development. Barbera M; Fitzgerald RC Surg Oncol Clin N Am; 2009 Jul; 18(3):393-410. PubMed ID: 19500732 [TBL] [Abstract][Full Text] [Related]
19. Histology of metaplasia and dysplasia in Barrett's esophagus. Yerian L Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733 [TBL] [Abstract][Full Text] [Related]
20. [The molecular genetic alterations in mucosa of intestines as markers of oncologic progression and estimate of effectiveness of anti-reflux operations in patients with Barrett's esophagus]. Osminin SV; Vetshev FP; Rudenko VV; Zaletaev DV; Khorobrykh TV; Nemtsova MV Klin Lab Diagn; 2016 Oct; 61(10):681-5. PubMed ID: 30615323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]